HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

CompletedOBSERVATIONAL
Enrollment

222,128

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

August 22, 2024

Study Completion Date

September 3, 2024

Conditions
HIV InfectionMDR-TB
Interventions
OTHER

Examination of HIV Infection in Patients with Multi-Drug Resistant Tuberculosis (MDR-TB)

This meta-analysis examines the impact of HIV infection on the prevalence and outcomes of multi-drug resistant tuberculosis (MDR-TB) among affected populations. The analysis synthesizes data from multiple studies conducted across various countries, focusing on the correlation between HIV co-infection and MDR-TB rates, treatment outcomes, and demographic factors. The findings aim to enhance understanding of the complex interactions between HIV and MDR-TB, ultimately informing clinical practices and public health strategies.

Trial Locations (1)

98167-43463

Zahedan University of Medical Sciences, Zahedan

All Listed Sponsors
lead

Zahedan University of Medical Sciences

OTHER

NCT06671808 - HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes | Biotech Hunter | Biotech Hunter